Literature DB >> 19767405

Foam sclerotherapy: techniques and uses.

Nisha Bunke1, Katherine Brown, John Bergan.   

Abstract

Sclerosant foam has been increasing in use in recent times. It has certain advantages over liquid sclerosants and is quite safe to use, despite the fact that there are adverse events that have been reported. The history of sclerosant foam goes back in time many years. Tessari developed the current method of creating sclerosant foam in 2001, and his technique has been modified. In our experience, the sclerosant foam has totally replaced other methods of treating venous insufficiency, and the results of treatment are superior to other methods. It is apparent that treatment of a variety of venous disorders can be accomplished using foam sclerotherapy. Our experience and that of others has shown that there are early advantages in the use of foam in the management of varicose veins compared with surgery and other methods.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767405     DOI: 10.1177/1531003509345286

Source DB:  PubMed          Journal:  Perspect Vasc Surg Endovasc Ther        ISSN: 1521-5768


  4 in total

1.  Prospective randomized trial of sclerotherapy vs standard treatment for epistaxis due to hereditary hemorrhagic telangiectasia.

Authors:  Holly Boyer; Patricia Fernandes; Chap Le; Bevan Yueh
Journal:  Int Forum Allergy Rhinol       Date:  2015-02-02       Impact factor: 3.858

2.  Endovascular laser therapy for varicose veins: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2010-04-01

3.  Endovascular radiofrequency ablation for varicose veins: an evidence-based analysis.

Authors: 
Journal:  Ont Health Technol Assess Ser       Date:  2011-02-01

4.  Benefits of polidocanol endovenous microfoam (Varithena®) compared with physician-compounded foams.

Authors:  Dario Carugo; Dyan N Ankrett; Xuefeng Zhao; Xunli Zhang; Martyn Hill; Vincent O'Byrne; James Hoad; Mehreen Arif; David D I Wright; Andrew L Lewis
Journal:  Phlebology       Date:  2015-06-01       Impact factor: 1.740

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.